Skip to main content
TipRanks
Go Ultimate75% OFF

James Armitage Insider Profile

4 Followers

James Armitage, Director at Cardiff Oncology, holds 13.00K shares in Cardiff Oncology (Ticker: CRDF), holds 0.00 shares in Tesaro (Ticker: TSRO). Most recently, James Armitage Bought ― shares of Cardiff Oncology on Oct 11, 2022 for an estimated value of $20.15K.

James Armitage's Trading History

CRDF
Cardiff Oncology
Oct 11, 2022DirectorInformative Buy20.15K$9.44K
TSRO
Tesaro
Jan 22, 2019―Uninformative Sell112.50K$0.00

You May Also Like

James Armitage insider profile FAQ

What is the percentage of profitable transactions made by James Armitage?
The percentage of profitable transactions made by James Armitage is 60%.
What is the average return per transaction made by James Armitage?
The average return per transaction made by James Armitage is 76.90%.
What stocks does James Armitage hold?
James Armitage holds: CRDF, TSRO stocks.
What was James Armitage’s latest transaction?
James Armitage’s latest transaction was an Informative Buy of $20.15K.
What was James Armitage's most profitable transaction?
James Armitage’s most profitable transaction was an Informative Buy of CRDF stock on May 18, 2020. The return on the trade was 371.00%.
What is James Armitage's role in Cardiff Oncology?
James Armitage's role in Cardiff Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.